Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation

64Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Aims: To analyse the visual and angiographic results of photodynamic therapy (PDT) with verteporfin in highly myopic patients with subfoveal choroidal neovascularisation (CNV). Methods: PDT was performed on highly myopic patients with subfoveal CNV. The patient population was divided into two groups according to age at onset of CNV (group 1 aged ≤ 55 and group 2 aged >55 years old). Best corrected visual acuity (BCVA) and angiographic findings were considered. Results: At the end of follow up group 2 had worse BCVA than group 1. 76% of patients in both groups showed a complete closure of CNV at the end of follow up. Conclusion: Visual prognosis of myopic CNV treated by PDT is influenced by age at onset.

Cite

CITATION STYLE

APA

Montero, J. A., & Ruiz-Moreno, J. M. (2003). Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. British Journal of Ophthalmology, 87(2), 173–176. https://doi.org/10.1136/bjo.87.2.173

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free